Literature DB >> 28286128

Deacylation Mechanism by SIRT2 Revealed in the 1'-SH-2'-O-Myristoyl Intermediate Structure.

Yi Wang1, Yi Man Eva Fung2, Weizhe Zhang3, Bin He4, Matthew Wai Heng Chung1, Jing Jin1, Jing Hu5, Hening Lin6, Quan Hao7.   

Abstract

Sirtuins are NAD-dependent deacylases. Previous studies have established two important enzymatic intermediates in sirtuin-catalyzed deacylation, an alkylamidate intermediate I, which is then converted to a bicyclic intermediate II. However, how intermediate II is converted to products is unknown. Based on potent SIRT2-specific inhibitors we developed, here we report crystal structures of SIRT2 in complexes with a thiomyristoyl lysine peptide-based inhibitor and carba-NAD or NAD. Interestingly, by soaking crystals with NAD, we capture a distinct covalent catalytic intermediate (III) that is different from the previously established intermediates I and II. In this intermediate, the covalent bond between the S and the myristoyl carbonyl carbon is broken, and we believe this intermediate III to be the decomposition product of II en route to form the end products. MALDI-TOF data further support the intermediate III formation. This is the first time such an intermediate has been captured by X-ray crystallography and provides more mechanistic insights into sirtuin-catalyzed reactions.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  crystallography; enzyme; post-translational modifications; reactive intermediates; sirtuins

Mesh:

Substances:

Year:  2017        PMID: 28286128      PMCID: PMC5365152          DOI: 10.1016/j.chembiol.2017.02.007

Source DB:  PubMed          Journal:  Cell Chem Biol        ISSN: 2451-9448            Impact factor:   8.116


  34 in total

1.  A SIRT2-Selective Inhibitor Promotes c-Myc Oncoprotein Degradation and Exhibits Broad Anticancer Activity.

Authors:  Hui Jing; Jing Hu; Bin He; Yashira L Negrón Abril; Jack Stupinski; Keren Weiser; Marisa Carbonaro; Ying-Ling Chiang; Teresa Southard; Paraskevi Giannakakou; Robert S Weiss; Hening Lin
Journal:  Cancer Cell       Date:  2016-05-09       Impact factor: 31.743

2.  Activation of the protein deacetylase SIRT6 by long-chain fatty acids and widespread deacylation by mammalian sirtuins.

Authors:  Jessica L Feldman; Josue Baeza; John M Denu
Journal:  J Biol Chem       Date:  2013-09-18       Impact factor: 5.157

3.  Insights into the sirtuin mechanism from ternary complexes containing NAD+ and acetylated peptide.

Authors:  Kevin G Hoff; José L Avalos; Kristin Sens; Cynthia Wolberger
Journal:  Structure       Date:  2006-08       Impact factor: 5.006

4.  SIRT1 deacetylation and repression of p300 involves lysine residues 1020/1024 within the cell cycle regulatory domain 1.

Authors:  Toula Bouras; Maofu Fu; Anthony A Sauve; Fang Wang; Andrew A Quong; Neil D Perkins; Ronald T Hay; Wei Gu; Richard G Pestell
Journal:  J Biol Chem       Date:  2005-01-04       Impact factor: 5.157

5.  Silent information regulator 2 potentiates Foxo1-mediated transcription through its deacetylase activity.

Authors:  Hiroaki Daitoku; Mitsutoki Hatta; Hitomi Matsuzaki; Satoko Aratani; Takayuki Ohshima; Makoto Miyagishi; Toshihiro Nakajima; Akiyoshi Fukamizu
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-25       Impact factor: 11.205

Review 6.  Sirtuins: NAD(+)-dependent deacetylase mechanism and regulation.

Authors:  Anthony A Sauve; Dou Yeon Youn
Journal:  Curr Opin Chem Biol       Date:  2012-10-23       Impact factor: 8.822

7.  N-lysine propionylation controls the activity of propionyl-CoA synthetase.

Authors:  Jane Garrity; Jeffrey G Gardner; William Hawse; Cynthia Wolberger; Jorge C Escalante-Semerena
Journal:  J Biol Chem       Date:  2007-08-07       Impact factor: 5.157

8.  Ex-527 inhibits Sirtuins by exploiting their unique NAD+-dependent deacetylation mechanism.

Authors:  Melanie Gertz; Frank Fischer; Giang Thi Tuyet Nguyen; Mahadevan Lakshminarasimhan; Mike Schutkowski; Michael Weyand; Clemens Steegborn
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-09       Impact factor: 11.205

9.  Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase.

Authors:  Jintang Du; Yeyun Zhou; Xiaoyang Su; Jiu Jiu Yu; Saba Khan; Hong Jiang; Jungwoo Kim; Jimin Woo; Jun Huyn Kim; Brian Hyun Choi; Bin He; Wei Chen; Sheng Zhang; Richard A Cerione; Johan Auwerx; Quan Hao; Hening Lin
Journal:  Science       Date:  2011-11-11       Impact factor: 47.728

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  11 in total

1.  A Small-Molecule SIRT2 Inhibitor That Promotes K-Ras4a Lysine Fatty-Acylation.

Authors:  Nicole A Spiegelman; Jun Young Hong; Jing Hu; Hui Jing; Miao Wang; Ian R Price; Ji Cao; Min Yang; Xiaoyu Zhang; Hening Lin
Journal:  ChemMedChem       Date:  2019-02-25       Impact factor: 3.466

2.  Identification of a novel small molecule that inhibits deacetylase but not defatty-acylase reaction catalysed by SIRT2.

Authors:  Norio Kudo; Akihiro Ito; Mayumi Arata; Akiko Nakata; Minoru Yoshida
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-06-05       Impact factor: 6.237

3.  Novel Lysine-Based Thioureas as Mechanism-Based Inhibitors of Sirtuin 2 (SIRT2) with Anticancer Activity in a Colorectal Cancer Murine Model.

Authors:  Ali Sohail Farooqi; Jun Young Hong; Ji Cao; Xuan Lu; Ian Robert Price; Qingjie Zhao; Tatsiana Kosciuk; Min Yang; Jessica Jingyi Bai; Hening Lin
Journal:  J Med Chem       Date:  2019-04-15       Impact factor: 7.446

Review 4.  Sirtuin Oxidative Post-translational Modifications.

Authors:  Kelsey S Kalous; Sarah L Wynia-Smith; Brian C Smith
Journal:  Front Physiol       Date:  2021-11-24       Impact factor: 4.566

5.  A Glycoconjugated SIRT2 Inhibitor with Aqueous Solubility Allows Structure-Based Design of SIRT2 Inhibitors.

Authors:  Jun Young Hong; Ian Robert Price; Jessica Jingyi Bai; Hening Lin
Journal:  ACS Chem Biol       Date:  2019-08-02       Impact factor: 5.100

6.  Hydrogen bonds are a primary driving force for de novo protein folding.

Authors:  Schuyler Lee; Chao Wang; Haolin Liu; Jian Xiong; Renee Jiji; Xia Hong; Xiaoxue Yan; Zhangguo Chen; Michal Hammel; Yang Wang; Shaodong Dai; Jing Wang; Chengyu Jiang; Gongyi Zhang
Journal:  Acta Crystallogr D Struct Biol       Date:  2017-11-10       Impact factor: 7.652

7.  Specific Recognition of Arginine Methylated Histone Tails by JMJD5 and JMJD7.

Authors:  Haolin Liu; Chao Wang; Schuyler Lee; Fangkun Ning; Yang Wang; Qianqian Zhang; Zhongzhou Chen; Jianye Zang; Jay Nix; Shaodong Dai; Philippa Marrack; James Hagman; John Kappler; Gongyi Zhang
Journal:  Sci Rep       Date:  2018-02-19       Impact factor: 4.379

8.  Potent mechanism-based sirtuin-2-selective inhibition by an in situ-generated occupant of the substrate-binding site, "selectivity pocket" and NAD+-binding site.

Authors:  Paolo Mellini; Yukihiro Itoh; Hiroki Tsumoto; Ying Li; Miki Suzuki; Natsuko Tokuda; Taeko Kakizawa; Yuri Miura; Jun Takeuchi; Maija Lahtela-Kakkonen; Takayoshi Suzuki
Journal:  Chem Sci       Date:  2017-07-21       Impact factor: 9.825

9.  Evolved, Selective Erasers of Distinct Lysine Acylations.

Authors:  Martin Spinck; Petra Neumann-Staubitz; Maria Ecke; Raphael Gasper; Heinz Neumann
Journal:  Angew Chem Int Ed Engl       Date:  2020-04-24       Impact factor: 15.336

10.  Nicotinamide inhibits melanoma in vitro and in vivo.

Authors:  Francesca Scatozza; Federica Moschella; Daniela D'Arcangelo; Stefania Rossi; Claudio Tabolacci; Claudia Giampietri; Enrico Proietti; Francesco Facchiano; Antonio Facchiano
Journal:  J Exp Clin Cancer Res       Date:  2020-10-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.